On Demand Webinars
-
Engaging Early In Process Development To Bring mRNA Sequences To Life
Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.
-
Accelerate Process Development With HTS Chromatography Tools
7/16/2024
High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. However, their use is less common in some modalities due to sample restrictions and the need for HTS expertise.
-
DNA Vaccine Development In A Global Pandemic: A Personal Account
4/14/2022
Dr. Gerrit Borchard, University of Geneva, presents a personal account of DNA vaccine development in a global pandemic.
-
Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders
Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.
-
Key Benefits Of PCR-Based mRNA Manufacturing For Clinical Development
6/12/2023
To unlock the potential of your mRNA therapies and accelerate your development and manufacturing program, discover the benefits of a novel PCR-based mRNA drug substance manufacturing process.
-
RNA Therapeutics: Going Beyond The Liver
4/14/2022
This TeaTime Webinar is presented by Dr. Dan Peer, Professor and Director, Laboratory of Precision NanoMedicine at Tel Aviv University.
-
Select An Ion-Pairing Agent For Impurity Analysis Of Oligonucleotides
5/4/2022
Learn about method development considerations when selecting an appropriate ion-pairing agent and impurity analysis of dye-conjugated oligonucleotides.
-
Planning for Success: Supply Resiliency Strategies for Bench to Production
10/18/2023
Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.
-
Translation Of RNA Nanomedicines From Design To Clinical
4/14/2022
mRNA therapeutics are applicable to cancer immunotherapies, infectious diseases, and other indications that require protein replacement therapy or antibodies.
-
Validation Of mRNA Concentration Determination
8/20/2023
mRNA-based therapeutics require comprehensive analytical testing to meet regulatory requirements. Optimize processes and ensure fast and reliable results as you bring your product to market.